Insider buying
~$1.27M200K sh @ $6.34
Traded May 2, 2025 · filed 3 days later
The CEO of Mimedx paid $1.27M out of pocket for Mimedx shares. Shares held went up 61% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MDXG · NASDAQ · Surgical & Medical Instruments & Apparatus
Mimedx Group (MDXG) · oqro.io/stocks/MDXG · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.05−0.06 (−1.93%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Insider buying
Traded May 2, 2025 · filed 3 days later
The CEO of Mimedx paid $1.27M out of pocket for Mimedx shares. Shares held went up 61% with this purchase.
Kimberly Maersk-moller (Chief Commercial Officer) sold ~$14K of Mimedx Group
Automatic saleWilliam Frank Iv Hulse (General Counsel and CAO) sold ~$270K of Mimedx Group
Automatic saleWilliam Frank Iv Hulse (General Counsel and CAO) sold ~$161K of Mimedx Group
Automatic saleKimberly Maersk-moller (Chief Commercial Officer) sold ~$32K of Mimedx Group
Automatic saleInsider selling
Traded Mar 10, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
Mimedx's General Counsel and CAO sold $635K of Mimedx shares. The filing does not indicate a pre-arranged trading plan.
Kimberly Maersk-moller (Chief Commercial Officer) sold ~$18K of Mimedx Group
Automatic saleRicci S Whitlow (Chief Operating Officer) sold ~$509K of Mimedx Group
Automatic sale0 open-market purchases and 0 open-market sales by insiders of MDXG between Jan 26, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 28, 2026. The data provider lists the next release for Feb 23, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Oct 28, 2026 | None | None | None |
| Jul 29, 2026 | None | None | None |
| Apr 29, 2026 | None | None | None |
| Feb 25, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies